Not Verified

Roche Canada Funding Request

Roche Canada

At Roche Canada, patients and science are at the heart of everything we do. Thus, we welcome opportunities to invest in initiatives and collaborate with organizations that drive healthcare forward. We are committed to delivering meaningful benefits to patients and a sustainable healthcare system.

Funding Opportunities

Roche Canada offers funding support in the form of sponsorships, grants, and international conference support (ICS).

We prioritize funding requests that:

Align with our focus areas and create opportunities in new areas, like artificial intelligence, innovation and real world evidence.
Improve patient care and outcomes.
Advance medical research and education.

Roche Canada also offers funding support in the form of philanthropic donations. We consider requests that explicitly align with our approach to philanthropy, which is rooted in a deep dedication to creating a better future for all.

We look to make a difference in these four areas:

Humanitarian and Social Projects
Science and Education Projects
Culture and Arts Projects
Community and Environment Projects

Applications for all four funding types are accepted throughout the year.

Evaluation Process

Every funding request received will be evaluated separately for alignment with Roche’s funding policy (including the Innovative Medicines Canada (IMC) code). Previous support by Roche for a similar request does not guarantee future support; and depending on the nature of the request, only partial support may be provided.

For information on the evaluation process, please review our process maps.

Submission Tips

Unfortunately, Roche is unable to support all funding request submissions. For funding consideration, please ensure that your submission has met all the relevant requirements and detailed information about the proposed initiative is provided.

As a reminder, only applications submitted through our online portal will be reviewed.

We highly recommend that applications for funding support be submitted as early as possible. For international conference support, applications must be submitted at least 45 days in advance of the conference start date. For other funding requests or conferences, please submit your application at least 60 days in advance of the start date to allow our teams adequate time to thoroughly review your request. Please note that a written agreement must be in place before the initiative/conference start date.

AI Based Application Success Predictor

1. Strong alignment with Roche therapeutic priorities ⭐⭐⭐⭐⭐

This is the most important predictor.

Competitive proposals should closely match:

Roche's therapeutic areas
The specific funding call
Medical or educational gaps identified by Roche
Areas of high unmet medical need
Roche's strategic healthcare priorities

Roche Canada explicitly states that funding requests are prioritized when they align with its areas of interest and create opportunities in areas such as AI, innovation, and real-world evidence.

2. Clear improvement in patient care and outcomes ⭐⭐⭐⭐⭐

Roche places strong emphasis on projects that can:

Improve patient outcomes
Improve diagnosis
Improve treatment
Enhance quality of care
Improve the patient journey
Address barriers to healthcare

A direct connection between the proposed initiative and measurable patient benefit substantially strengthens an application.

3. Addressing an important unmet medical need ⭐⭐⭐⭐⭐

Strong proposals clearly identify an existing gap, such as:

Unmet treatment needs
Delayed diagnosis
Lack of healthcare professional knowledge
Treatment access barriers
Disease-management gaps
Healthcare-system inefficiencies
Evidence gaps

Roche specifically indicates that it prefers investments that address high unmet medical needs.

4. Scientific and medical quality ⭐⭐⭐⭐⭐

For research-related requests, competitive applications should demonstrate:

Strong scientific rationale
Appropriate study design
Reliable methodology
Relevant preliminary evidence where appropriate
Appropriate outcome measures
Qualified investigators

Roche supports investigator-initiated clinical studies, including Phase I–IV interventional studies, as well as observational and real-world evidence studies in relevant therapeutic areas.

5. Innovation and novel approaches ⭐⭐⭐⭐⭐

Roche Canada specifically identifies innovation and artificial intelligence among areas where it is interested in new opportunities.

Competitive proposals may involve:

AI and machine learning
Digital health
Personalized medicine
Novel diagnostics
Precision healthcare
Real-world data
New models of healthcare delivery

6. Personalized healthcare and real-world evidence ⭐⭐⭐⭐⭐

Projects that use real-world evidence or support personalized healthcare can be particularly well aligned with Roche's current strategy.

Examples include:

Real-world clinical data
Patient-level outcomes
Precision medicine
Treatment-response analysis
Healthcare utilization studies
Evidence generation for clinical decision-making

Roche Canada explicitly identifies personalized healthcare and real-world evidence as areas of increased interest.

7. Strong patient engagement ⭐⭐⭐⭐☆

Roche Canada has made patient partnership an important component of its healthcare approach.

Competitive initiatives can demonstrate:

Patient involvement in project design
Patient-reported outcomes
Caregiver engagement
Patient advisory groups
Patient-centered outcome measures
Co-creation with patient organizations

Roche Canada describes patient partnership and lived experience as important elements of its decision-making and healthcare work.

8. Potential for broader healthcare-system impact ⭐⭐⭐⭐☆

Strong projects should demonstrate benefits beyond a single institution where possible.

Examples include:

Improving healthcare delivery
Supporting healthcare professionals
Improving access to care
Developing transferable educational resources
Improving clinical pathways
Supporting sustainable healthcare systems

Roche specifically states that it is interested in initiatives that improve the healthcare and patient ecosystem as a whole.

9. Strong investigator/organization capability ⭐⭐⭐⭐☆

Competitive applications should demonstrate:

Qualified investigators or project leaders
Appropriate institutional expertise
Relevant clinical/scientific experience
Adequate infrastructure
Appropriate collaborators
Ability to deliver the proposed initiative

For research projects, a credible investigator and capable research environment are especially important.

10. Complete, compliant, and timely application ⭐⭐⭐⭐☆

Roche Canada requires funding requests to be submitted through its online funding system.

Applicants should provide:

Complete project description
Clear objectives
Detailed budget
Appropriate supporting documentation
Eligibility information
Appropriate timeline

Roche notes that requests must be submitted through its online portal and recommends submitting sufficiently early for review. For most requests, it recommends at least 60 days before the initiative begins; international conference requests should generally be submitted at least 45 days beforehand.

Specialties

Hematology

Oncology

Rare Diseases

Immunology

Ophthalmology

Eligibility Requirements

Roche can only consider funding requests submitted on behalf of and intended for eligible applicants and initiatives.

Eligible Countries:

Canada

Sponsor Details

Sponsor Institute/Organizations: Roche Canada

Sponsor Type: Corporate/Non-Profit

Address: Hoffmann-La Roche Limited, 7070 Mississauga Road, Mississauga, ON L5N 5M8

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity